MedPath

Conservative Therapy of Proximal Phalanx Fractures - Comparing the Lucerne Cast With Finger Splinting

Not Applicable
Recruiting
Conditions
Proximal Phalanx Fracture
Registration Number
NCT06022419
Lead Sponsor
Medical University of Vienna
Brief Summary

The purpose of this prospective randomized controlled clinical trial is to evaluate if the lucerne cast leads to a better functional outcome than a forearm cast with a finger splint in patients with a proximal phalanx fracture.

Detailed Description

This study represents a prospective randomized controlled clinical trial comparing two different conservative treatment options in patients with proximal phalanx fractures.

Patients meeting the inclusion criteria will be enrolled in the present study provided they give their consent. Informed written consent will be obtained. Randomization will be performed according to the CONSORT Guidelines of Prospective Randomized Trials using the software "Randomizer" by the Medical University of Graz. Patients allocated to the control group will receive a forearm cast with a finger splint, while patients in the study group will receive the lucerne cast. Both groups will receive the allocated cast for 4 weeks. Clinical outcome will be assessed 12 weeks after trauma.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Proximal phalanx fracture in the fingers (II - V)
  • Patient age between 18 and 70 years
Exclusion Criteria
  • Condylar fracture
  • Avulsions of the collateral ligament
  • Pathologic fracture
  • Intraarticular fracture
  • Patients unable to consent
  • Polytraumatized patients
  • Patients initially presenting more than 7 days after injury
  • Pregnancy
  • Compound fractures
  • Multiple hand injuries

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Brief Michigan-Hand-Outcome-Questionnaireat 12 weeks

patient-based standardised questionnaire (12 items, range 0-100, 100=ideal function, 0=poorest function)

Secondary Outcome Measures
NameTimeMethod
Treatment Failureat 1, 2, 4 and 12 weeks

Occurrence of indication for surgery (malrotation, axial deviation \>10°, dorsal angulation \>20°) after primary reposition

Trial Locations

Locations (1)

Medical University of Vienna - Department of Orthopedics and Trauma-Surgery

🇦🇹

Vienna, Austria

Medical University of Vienna - Department of Orthopedics and Trauma-Surgery
🇦🇹Vienna, Austria
Paul Hoppe, M.D.
Contact
+4314040059160
paul.hoppe@meduniwien.ac.at

© 2025 MedPath, Inc. All rights reserved.